20.49 USD
▲+0.17+0.84%
盘后 24.64 0.00%
2026-09-16
市值
$74.35M
市盈率
—
EPS
-26.36
股息率
—
52 周区间
18.19 – 37.50
成交量
33.56K
Beta
3.04
目标价
53.14
52W 低 18.1952W 高 37.50
价格走势
公司简介
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestati...